Oncotarget.net features press releases on the latest oncology research, as well as interviews from the distinguished network of authors who continue to publish their research with Oncotarget.

Category: Oncotarget

Figure 3: Similar gene expression patterns between endocrine-resistant breast cancer and triple-negative breast cancer.

Oncotarget

Novel Group of Genes That Cause Endocrine Resistance in Breast Cancer Identified by Dynamic Gene Expression Analysis

June 8, 2022

“Our findings identify 34 novel genes for further study as potential therapeutic targets for treatment of endocrine-resistant BC and TNBC.” Listen to an audio version of this press release BUFFALO,… read more

Figure 1: Development of an NF-κB activity related RNA expression classifier.

Oncotarget

Oncotarget | NF-κB Over-Activation Portends Improved Outcomes in HPV+ HNSCC

May 25, 2022

“Since clinicians are exploring therapeutic deintensification for HPV+ HNSCC, identifying patients with good or poor prognosis using the NF-κB Activity Classifier may be useful to guide therapeutic decisions.” Listen to… read more

CancerOmicsNet: a multi-omics network-based approach to anti-cancer drug profiling

Oncotarget

Anti-Cancer Drug Profiling With CancerOmicsNet

May 19, 2022

Listen to an audio version of this press release BUFFALO, NY- May 19, 2022 – A new research paper was published in Volume 13 of Oncotarget, entitled, “CancerOmicsNet: a multi-omics… read more

Oncotarget

Impact Journals to Present Scientific Integrity Process at 2022 SSP Annual Meeting

May 16, 2022

Impact Journals is a supporter and exhibitor at the Society for Scholarly Publishing (SSP) 44th Annual meeting—taking place from June 1–3, 2022, at the Sheraton Grand Chicago Riverwalk in Chicago.… read more

Oncotarget

Testimonial: Dr. Mark Woodford

May 3, 2022

Dr. Mark Woodford, Assistant Professor at the Department of Urology, SUNY Upstate Medical University, Syracuse, NY, describes his experience publishing the meeting report, “Seventh BHD international symposium: recent scientific and… read more

Figure 2: TMB distribution in non-small cell lung cancer

Oncotarget

Mutational Burden in Lung Cancer Studied in Multisite Cohort

April 25, 2022

Listen to an audio version of this press release BUFFALO, NY-April 25, 2022 – A new research paper, entitled, “Real-world survival analysis by tumor mutational burden in non-small cell lung… read more

Dr. Stanley Lipkowitz and Dr. Yoshimi Endo Greer

Oncotarget

Behind the Study: How ONC201 Kills Breast Cancer Cells

April 22, 2022

Dr. Stanley Lipkowitz and Dr. Yoshimi Endo Greer from the Women’s Malignancies Branch at the National Cancer Institute discuss a research paper they co-authored that was published by Oncotarget in… read more

Oncotarget

Behind the Study: Breast Cancer Cells and MSC Actions

April 14, 2022

Jonathan Kelber and Francesca Sanchez from the Department of Biology, California State University Northridge, Northridge CA, discuss a research paper they co-authored for Oncotarget in 2019, entitled, "Secretomes from metastatic… read more

Mariana Perepitchka, Yekaterina Galat, and Dr. Vasiliy Galat

Oncotarget

Behind the Study: Endothelial Perspective on Tumor Development

April 1, 2022

Mariana Perepitchka, Yekaterina Galat, and Dr. Vasiliy Galat discuss their 2020 research paper published by Oncotarget, entitled, "Down syndrome iPSC model: endothelial perspective on tumor development." Listen to an audio… read more

Oncotarget

Impact Journals at AACR Annual Meeting 2022

March 28, 2022

Listen to an audio version of this announcement BUFFALO, NY-March 28, 2022 – Impact Journals publishes scholarly journals in biomedical sciences with a focus on all areas of cancer and aging research. Impact… read more